Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G C Doveil

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Journal of Tissue Reactions|January 1, 1984
Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanomaM G Bernengo, F Lisa, M Meregalli, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|April 1, 1987
[Heterogenicity of T-cell cutaneous lymphomas: pleomorphic lymphoma of intermediate phenotype between the thymic and post-thymic stages. Study of 2 cases]M G Bernengo, L Musso, M Novelli, et al.
The British Journal of Dermatology|August 1, 1988
Immunomodulation and Sézary syndrome: experience with thymopentin (TP-5)M G Bernengo, G C Doveil, M Meregalli, et al.
Minerva Medica|September 1, 1996
[Psychiatry and dermatologic neoplasms: results of an experimental study]G Angelini, C Donadio, G C Doveil, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|April 1, 1987
[Cutaneous melanoma at the Turin Melanoma Center. II. Risk of metastasis and free interval in relation to the clinical and histological prognostic factors in 502 patients in stage I (1975-1985)]M G Bernengo, G C Doveil, F Lisa, et al.
Melanoma Research|September 1, 1992
BANS: a discussion of the problemM G Bernengo, U M Reali, G C Doveil, et al.
Dermatology (Basel, Switzerland)|January 1, 1997
Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphomaM T Fierro, G C Doveil, P Quaglino, et al.
Journal of the National Cancer Institute|September 2, 1992
Thymopentin in Sézary syndromeM G Bernengo, A Appino, M Bertero, et al.
Melanoma Research|April 1, 1993
Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifenM T Fierro, M Bertero, M Novelli, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|April 1, 1988
[Role of interferon alfa-2 in melanoma. Results of a phase II study in 27 patients]M G Bernengo, G C Doveil, A Appino, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Tissue Reactions|January 1, 1984
Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanomaM G Bernengo, F Lisa, M Meregalli, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|April 1, 1987
[Heterogenicity of T-cell cutaneous lymphomas: pleomorphic lymphoma of intermediate phenotype between the thymic and post-thymic stages. Study of 2 cases]M G Bernengo, L Musso, M Novelli, et al.
The British Journal of Dermatology|August 1, 1988
Immunomodulation and Sézary syndrome: experience with thymopentin (TP-5)M G Bernengo, G C Doveil, M Meregalli, et al.
Minerva Medica|September 1, 1996
[Psychiatry and dermatologic neoplasms: results of an experimental study]G Angelini, C Donadio, G C Doveil, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|April 1, 1987
[Cutaneous melanoma at the Turin Melanoma Center. II. Risk of metastasis and free interval in relation to the clinical and histological prognostic factors in 502 patients in stage I (1975-1985)]M G Bernengo, G C Doveil, F Lisa, et al.
Melanoma Research|September 1, 1992
BANS: a discussion of the problemM G Bernengo, U M Reali, G C Doveil, et al.
Dermatology (Basel, Switzerland)|January 1, 1997
Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphomaM T Fierro, G C Doveil, P Quaglino, et al.
Journal of the National Cancer Institute|September 2, 1992
Thymopentin in Sézary syndromeM G Bernengo, A Appino, M Bertero, et al.
Melanoma Research|April 1, 1993
Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifenM T Fierro, M Bertero, M Novelli, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|April 1, 1988
[Role of interferon alfa-2 in melanoma. Results of a phase II study in 27 patients]M G Bernengo, G C Doveil, A Appino, et al.
Pageof 2